Anatomical location and lesion characteristics | Black patients n (%) | Non-Black patients n (%) | P value* | Multivariable OR (95% CI)†‡§ | P value†‡§ |
Erythema in any location | 99 (88) | 63 (89) | 0.944 | N/A | N/A |
Scale in any location | 78 (69) | 53 (75) | 0.464 | N/A | N/A |
Dyspigmentation in any location | 111 (99) | 56 (79) | <0.001 | 48.94 (5.82 to 411.77)¶ | <0.001 |
Scarring in any location | 100 (89) | 55 (77) | 0.030 | N/A | N/A |
Scalp | |||||
Erythema | 75 (59) | 42 (67) | 0.284 | N/A | N/A |
Scale/hypertrophy | 58 (52) | 34 (48) | 0.607 | N/A | N/A |
Dyspigmentation | 92 (82) | 32 (48) | <0.001 | 5.85 (2.94 to 11.61)** | <0.001 |
Scarring alopecia | 89 (79) | 40 (56) | 0.001 | 3.00 (1.56 to 5.78)†† | 0.001 |
Non-scarring alopecia | 49 (44) | 29 (41) | 0.699 | N/A | N/A |
Ears | |||||
Erythema | 36 (32) | 20 (28) | 0.570 | N/A | N/A |
Scale/hypertrophy | 34 (30) | 22 (31) | 0.928 | N/A | N/A |
Dyspigmentation | 63 (56) | 25 (35) | 0.006 | 2.89 (1.50 to 5.54)‡‡ | 0.001 |
Scarring | 31 (28) | 14 (20) | 0.223 | N/A | N/A |
*P value was calculated with χ2 test.
†Blank values represented by ‘–’ indicate variables for which race was not a significant factor in the multivariable analyses.
‡N/A represents values for which multivariable analyses were not performed.
§Predictor variables (race, age at initial visit, gender, disease duration at initial visit, follow-up duration, smoking status, presence of SLE) were included in multivariable analyses.
¶Race and age at initial visit (OR=0.92, 95% CI 0.88 to 0.97, p=0.002) were significant predictors of dyspigmentation in any anatomical location.
**Race and follow-up duration (OR=1.17, 95% CI 1.01 to 1.36, p=0.04) were significant predictors of scalp dyspigmentation.
††Race was the only significant predictor of scarring alopecia.
‡‡Race and age at initial visit (OR=0.96, 95% CI 0.94 to 0.98, p=0.001) were also significant predictors of ear dyspigmentation.
CI, confidence interval; CLASI, Cutaneous Lupus Erythematosus Disease Area and Severity Index; DLE, discoid lupus erythematous; N/A, not available; OR, odds ratio.